New biotech venture fund capitalized at $300 million

Pivotal bioVenture Partners2Pivotal bioVenture Partners closed its first fund last week, securing $300 million to invest in biotech start-ups. Click here to learn more about the new fund.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.